NASDAQ: ESLA - Estrella Immunopharma, Inc.

Yield per half year: +16.51%
Dividend yield: 0.00%

Estrella Immunopharma, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 0 0% -280.83 -100%
P/S 0 0 0%
P/BV 8.77 0 0%
P/FCF 0 0 0%
Ev/Ebitda -39.81 0 0%
Ev/S 0 0 0%
Ev/FCF -62.5 0 0%
E/P 0 0 0%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 0 0% 0 0%
ROE -33.03 0 0%
ROA -13.36 0 0%
ROIC 0 0 0%
ROS 0 0 0%
ROCE -124.69 0 0%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.3119 0 0% -0.2921 +6.77%
Nеt Debt/Ebitda -0.2863 0 0%
Debt/Ratio 0.0499 0 0%
Debt/Equity 0 0 0%
Debt/Net Income -0.501 0 0%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0 0% 0 0%
Number of years of dividend growth 0 0 0%
DSI 0 0 0%
Average dividend growth 0 0 0%
Average percentage for 5 years 0 0 0%
Average percentage for payments 0 0 0%
Difference from average difference in sector 0

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
0 0 0%
Growth impulse Ebitda in 5 years 117.98 0 0%
Growth impulse Net Income in 5 years 896.15 0 0%
Growth impulse FCF in 5 years 2294.68 0 0%
Growth impulse EPS in 5 years 868.68 0 0%
IP Score
3.73/10

Similar companies

Mercurity Fintech Holding Inc.

Turnstone Biologics Corp. Common Stock

SenesTech, Inc.

Complete Solaria, Inc.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription